Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Omega-3 Fatty Acids and Muscle Protein Synthesis
This study is currently recruiting participants.
Verified by Washington University School of Medicine, December 2008
Sponsors and Collaborators: Washington University School of Medicine
Longer Life Foundation
American Federation for Aging Research
Reliant Pharmaceuticals
Information provided by: Washington University School of Medicine
ClinicalTrials.gov Identifier: NCT00794079
  Purpose

The purpose of this study is to determine whether omega-3 fatty acid supplementation influences muscle protein synthesis rates in young and older adults.


Condition Intervention
Healthy
Dietary Supplement: omega-3 fatty acids
Dietary Supplement: corn oil

MedlinePlus related topics: Dietary Supplements
Drug Information available for: Omacor
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Omega-3 Fatty Acids and Muscle Protein Synthesis

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Evaluate the effect of omega-3 fatty acid supplementation on skeletal muscle protein synthesis rates both in the basal, postabsorptive state and in response to infusion of insulin and amino acids in young and older adults [ Time Frame: Measurements taken prior to and following 8 weeks of supplementation ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Evaluate the effect of omega-3 fatty acid supplementation on anabolic signaling pathways in skeletal muscle [ Time Frame: Measurements taken prior to and following 8 weeks of supplementation ] [ Designated as safety issue: No ]
  • Evaluate the effect of omega-3 fatty acid supplementation on inflammatory cytokines in the systemic circulation and inflammatory signaling pathways in skeletal muscle [ Time Frame: Measurements taken prior to and following 8 weeks of supplementation ] [ Designated as safety issue: No ]
  • Compare muscle protein synthesis rates between men and women in the basal, postabsorptive state and in response to insulin and amino acid infusion [ Time Frame: prior to supplementation only ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: June 2007
Estimated Study Completion Date: June 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
omega-3 fatty acids
Dietary Supplement: omega-3 fatty acids
4 grams per day for 8 weeks
B: Placebo Comparator
corn oil
Dietary Supplement: corn oil
4 grams per day for 8 weeks

Detailed Description:

Loss of muscle mass is a normal consequence of aging. The decline in muscle mass is estimated to be 0.2-0.5% per year from 60 years old onwards in healthy subjects with the decline worsened by chronic illness, poor appetite and diet, and reduced physical activity in the elderly. Increased morbidity is demonstrable with as little as a 5% loss of muscle mass - therefore, treatments that can prevent or slow the progression of muscle loss with aging are much desired.

A major cause for loss of muscle mass in advanced age appears to be an impaired ability to stimulate the synthesis of muscle protein in response to increased levels of amino acids (the building blocks of proteins) and insulin as occurs after eating because of low-grade inflammation and insulin resistance in muscle of old persons. We propose that long-chain omega-3 polyunsaturated fatty acids (fish oil) slow the loss of muscle mass because fish oil has anti-inflammatory properties and increases the sensitivity of muscle protein synthesis to insulin and amino acids. We will test this by studying the effect of fish oil supplementation on the muscle protein synthesis process in young and older adults.

Please note we have completed recruitment for the younger (18 to 45 year old) group and are therefore currently only recruiting individuals aged between 65 and 85 years.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Body mass index (BMI) < 30 kg/m2;
  • Age 18-45 yr; or
  • Age 65-85 yr

Exclusion Criteria:

  • Those taking medications known to affect substrate metabolism or medications that may confound the findings from our study (synthetic steroids, glucocorticoids etc.);
  • Those with evidence of significant organ system dysfunction (e.g. diabetes mellitus, cirrhosis, hypo- or hyperthyroidism; hypertension);
  • Body mass index > 30 kg/m2
  • Age <18 yr, 45-65 yr or > 85 yr
  • Those performing >1.5h of exercise/wk
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00794079

Contacts
Contact: Gordon I Smith, PhD 362-4375 gsmith@dom.wustl.edu

Locations
United States, Missouri
Washington University in Saint Louis Recruiting
Saint Louis, Missouri, United States, 63110
Contact: Gordon I Smith, PhD     314-362-4375     gsmith@dom.wustl.edu    
Principal Investigator: Bettina Mittendorfer, PhD            
Sponsors and Collaborators
Washington University School of Medicine
Longer Life Foundation
American Federation for Aging Research
Reliant Pharmaceuticals
Investigators
Principal Investigator: Bettina Mittendorfer, PhD Washington University School of Medicine
  More Information

Responsible Party: WashingtonU ( Bettina Mittendorfer, PhD )
Study ID Numbers: 06-1147
Study First Received: November 18, 2008
Last Updated: December 5, 2008
ClinicalTrials.gov Identifier: NCT00794079  
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
Healthy volunteers
young adults
Aged

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on January 14, 2009